Additionally, miR-181a has been shown to modulate PRKN (Parkin) expression, thereby promoting mitophagy, the selective clearance of damaged mitochondria, which is critical for maintaining mitochondrial quality control in PD [29]. Here, PRKN is linked to Parkinson disease.